S. Sedlis

发表

Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).

D. Berman, J. Spertus, P. Hartigan, 2015, The American journal of cardiology.

Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence

N. Smilowitz, S. Sedlis, B. Naoulou, 2015, Current Atherosclerosis Reports.

Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study.

I. Kronzon, S. Sedlis, J. Cohen, 1997, Journal of the American College of Cardiology.

Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina.

W. Henderson, G. Sethi, K. Ramanathan, 2005, The Annals of thoracic surgery.

CORONARY ARTERY DISEASE Plasma apoproteins and the severity of coronary artery disease *

P. Ludbrook, K. Schechtman, B. Sobel, 2005 .

Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

D. Berman, L. Shaw, J. Spertus, 2009, The American journal of cardiology.

Beta Adrenergic Stimulation and Blockade in Cirrhosis: Effects on Azygos Vein Blood Flow and Portal Hemodynamics

S. Sedlis, E. Weinshel, R. Raicht, 1994, The American journal of the medical sciences.

Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th

F. Welt, F. Grover, M. Krucoff, 2001, Journal of the American College of Cardiology.

Should Fractional Flow Reserve Be Measured After Stent Deployment? Routinely? Ever?

S. Sedlis, J. Lorin, 2017, JACC. Cardiovascular interventions.

Percutaneous coronary intervention: FAME is lasting

S. Sedlis, J. Lorin, 2015, The Lancet.

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.

D. Berman, J. Spertus, P. Hartigan, 2018, Journal of the American College of Cardiology.

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

J. Spertus, B. Chaitman, P. Hartigan, 2013, Journal of the American College of Cardiology.

Relation of elevated periprocedural blood glucose to long-term survival after percutaneous coronary intervention.

Binita Shah, E. Grossi, S. Sedlis, 2005, The American journal of cardiology.

Frontrunner CTO technology

C. Kliger, S. Sedlis, J. Lorin, 2013 .

Prognostic significance of spontaneous echo contrast in the thoracic aorta: relation with accelerated clinical progression of coronary artery disease.

M. Sanfilipo, A. Marcus, S. Sedlis, 1997, Journal of the American College of Cardiology.

The assessment of thrombotic markers utilizing ionic versus non‐ionic contrast during coronary angiography and intervention trial

Binita Shah, J. Berger, Yu Guo, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Metabolic syndrome does not impact survival in patients treated for coronary artery disease

Binita Shah, E. Grossi, S. Sedlis, 2008, Coronary artery disease.

A dual wire approach to severe ostial bifurcating renal artery stenosis

David S. Hirsh, S. Sedlis, M. Attubato, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina

Olga V. Patterson, S. Duvall, J. Herrick, 2019, Journal of the American Heart Association.

Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease

Binita Shah, S. Sedlis, F. Ujueta, 2017, Current Cardiology Reports.

Elevated Prothrombin and Activated Protein C Resistance in Patients with Thoracic Aortic Atheroma

P. Tunick, S. Sedlis, A. Schwartzbard, 2002, Angiology.

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy: Observations From the COURAGE Trial

D. Berman, L. Shaw, J. Spertus, 2011, Circulation. Cardiovascular interventions.

Percutaneous revascularization for stable coronary artery disease: temporal trends and impact of drug-eluting stents.

W. Boden, S. Sedlis, 2010, JACC. Cardiovascular interventions.

Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial

D. Berman, L. Shaw, J. Spertus, 2009, Circulation. Cardiovascular quality and outcomes.

Re: One year perspective on COURAGE

D. Berman, R. O'rourke, W. Boden, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.

David L. Brown, L. Pilote, K. Mak, 2003, The Canadian journal of cardiology.

Evaluation of routine functional testing after percutaneous coronary intervention.

M. Starling, R. Beyar, L. Pilote, 2004, The American journal of cardiology.

A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of

F. Grover, M. Krucoff, F. Duhaylongsod, 1999, Controlled clinical trials.

Dobutamine stress testing in the cardiac catheterization laboratory.

S. Sedlis, K. Kumar, A. Matalon, 1996, The American journal of cardiology.

Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial

Daniel S Berman, Mihaela Aslan, Paul Kolm, 2013, Circulation. Cardiovascular quality and outcomes.

A risk score for prediction of hyperglycemia at coronary angiography.

Binita Shah, I. Lobach, S. Sedlis, 2014, JACC. Cardiovascular interventions.

Effectiveness of fluorography versus cineangiography at reducing radiation exposure during diagnostic coronary angiography.

Binita Shah, S. Bangalore, J. Slater, 2014, The American journal of cardiology.

Time course of lysophosphatidylcholine release from ischemic human myocardium parallels the time course of early ischemic ventricular arrhythmia.

A. Jaffe, J. Ladenson, J. M. Sequeira, 1997, Coronary artery disease.

Lysophosphatidylcholine accumulation in ischemic human myocardium.

J. M. Sequeira, S. Sedlis, M. Hom, 1993, The Journal of laboratory and clinical medicine.

Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis.

M. Radford, Binita Shah, N. Smilowitz, 2016, International journal of cardiology.

Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

J. Spertus, Binita Shah, B. Chaitman, 2022, The American journal of cardiology.

Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Binita Shah, J. Berger, Nicole Allen, 2016, Inflammation.

Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial).

D. Berman, L. Shaw, J. Spertus, 2012, The American journal of cardiology.

Rapid thrombectomy for treatment of macroembolization during percutaneous coronary intervention in the setting of acute myocardial infarction

S. Sedlis, J. Lorin, Michael C. Liou, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of six-month outcomes of percutaneous transluminal coronary angioplasty in patients > or =75 with those <75 years of age (the ROSETTA registry).

K. Mak, D. Brieger, T. Huynh, 2001, The American journal of cardiology.

Cardiac amyloidosis simulating hypertrophic cardiomyopathy.

A. Jaffe, S. Sedlis, J. Saffitz, 1984, The American journal of cardiology.

Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice.

M. Radford, Binita Shah, L. Rolnitzky, 2012, Archives of internal medicine.

The right radial approach for stenting of lesions in the right coronary artery with anomalous take-off from the left sinus of valsalva.

S. Sedlis, A. Lorenzo, J. Lorin, 2000, The Journal of invasive cardiology.

Lysophosphatidyl choline potentiates Ca2+ accumulation in rat cardiac myocytes.

P. Corr, B. Sobel, S. Sedlis, 1983, The American journal of physiology.

Long-Term Prognostic Signiﬁcance of Dobutamine Echocardiography in Patients With Suspected Coronary Artery Disease: Results of a 5-Year Follow-Up Study

I. Kronzon, S. Sedlis, E. Steinberg, 2016 .

Preservation of left ventricular function in patients with total occlusion of the left anterior descending coronary artery and wide-caliber distal vessel filling by collateral vasculature.

J. M. Sequeira, N. el-Sherif, S. Sedlis, 1988, Catheterization and cardiovascular diagnosis.

Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction

Binita Shah, P. Subramanyam, N. Smilowitz, 2017, Coronary artery disease.

Racial differences in performance of invasive cardiac procedures in a Department of Veterans Affairs Medical Center.

S. Sedlis, E. Steinberg, L. Madmon, 1997, Journal of clinical epidemiology.

Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry.

David L. Brown, K. Mak, D. Brieger, 2004, The Canadian journal of cardiology.

Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction

Binita Shah, S. Sedlis, N. Amoroso, 2012, The American journal of the medical sciences.

Potentiation of the depressant effects of lysophosphatidylcholine on contractile properties of cultured cardiac myocytes by acidosis and superoxide radical.

J. M. Sequeira, S. Sedlis, H. Altszuler, 1990, The Journal of laboratory and clinical medicine.

Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout

J. Greenberg, B. Cronstein, M. Pillinger, 2012, The Journal of Rheumatology.

Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.

D. Berman, L. Shaw, J. Spertus, 2009, Journal of the American College of Cardiology.

Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry).

Jerome Sacks, William Henderson, W. Henderson, 2004, The American journal of cardiology.

Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry.

Jerome Sacks, William Henderson, Herbert Ward, 2002, Journal of the American College of Cardiology.

Glycemic Control in Coronary Revascularization

Binita Shah, S. Sedlis, F. Ujueta, 2016, Current Treatment Options in Cardiovascular Medicine.

Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)

D. Berman, J. Spertus, P. Hartigan, 2018, Circulation. Cardiovascular quality and outcomes.

Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.

Yuan Kong, R. Roubenoff, A. Pursnani, 2011, The Journal of clinical endocrinology and metabolism.

Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention

Binita Shah, E. Fisher, Lisa Tully, 2015, Diabetes/metabolism research and reviews.

Comparison of platelet activity measurements by use of arterial and venous blood sampling

J. Berger, S. Sedlis, N. Amoroso, 2013, Journal of thrombosis and haemostasis : JTH.

Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial.

Jerome Sacks, William Henderson, F. Welt, 2002, Journal of the American College of Cardiology.

Mitchell W. Krucoff, William G. Henderson, David C. Booth, 2001, Journal of the American College of Cardiology.

Avoiding stent thrombosis: advances in technique, antiplatelet pharmacotherapy and stent design

S. Sedlis, V. Madan, J. Coppola, 2013 .

The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina

D. Berman, L. Shaw, J. Spertus, 2011, Circulation. Cardiovascular quality and outcomes.

Use of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA Registry.

L. Pilote, K. Mak, D. Brieger, 2001, American heart journal.

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.

D. Berman, L. Shaw, J. Spertus, 2010, Journal of the American College of Cardiology.

Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).

J. Spertus, B. Chaitman, P. Hartigan, 2015, American Journal of Cardiology.

Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.

D. Berman, L. Shaw, J. Spertus, 2014, JACC. Cardiovascular interventions.

Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.

J. Spertus, P. Hartigan, R. O'rourke, 2009, The American journal of cardiology.

Predictors of oxidative stress in heart failure patients with Cheyne–Stokes respiration

A. Krieger, S. Sedlis, D. Green, 2011, Sleep and Breathing.

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.

Daniel Berman, William S Weintraub, John A Spertus, 2015, The New England journal of medicine.

Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome

Binita Shah, S. Sedlis, J. Lorin, 2016, Current Cardiology Reports.

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.

D. Berman, J. Spertus, B. Chaitman, 2013, American heart journal.

Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Heart Failure With Reduced Left Ventricular Ejection Fraction.

L. Axel, Binita Shah, L. Rolnitzky, 2015, The American journal of cardiology.

Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease

Binita Shah, R. Donnino, E. Grossi, 2012, Coronary artery disease.

Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

Hongjian Zhu, Johannes Rieber, Gilles Rioufol, 2014, Journal of the American College of Cardiology.

Comparison of quantity of left ventricular scarring and remodeling by magnetic resonance imaging in patients with versus without diabetes mellitus and with coronary artery disease.

J. Babb, M. Srichai, R. Donnino, 2011, The American journal of cardiology.

The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.

M. J. Broekman, A. Marcus, S. Sedlis, 2005, Thrombosis research.

Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.

D. Berman, L. Shaw, J. Spertus, 2011, Journal of the American College of Cardiology.

Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Binita Shah, J. Berger, Nicole Allen, 2016, Inflammation.

Association Between Gout and Aortic Stenosis.

M. Pillinger, R. Donnino, C. Oh, 2017, The American journal of medicine.

Plasma apoproteins and the severity of coronary artery disease.

B E Sobel, P. Ludbrook, K. Schechtman, 1986, Circulation.

Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients.

Jerome Sacks, F. Grover, W. Henderson, 2002, Journal of the American College of Cardiology.

Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention.

Binita Shah, J. Berger, I. Lobach, 2013, The American journal of cardiology.

Relationship between neutrophil-lymphocyte ratio and severity of lower extremity peripheral artery disease.

Binita Shah, M. Pillinger, C. Staniloae, 2017, International journal of cardiology.

Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.

Binita Shah, J. Berger, Yu Guo, 2014, The American journal of cardiology.

Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).

D. Berman, L. Shaw, J. Spertus, 2009, The American journal of cardiology.

Mechanisms of ventricular arrhythmias in acute ischemia and reperfusion.

S. Sedlis, 1991, Cardiovascular clinics.

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).

J. Spertus, P. Hartigan, D. Goldfarb, 2013, The American journal of cardiology.

IMPACT OF PRETREATMENT ISCHEMIA ON THERAPEUTIC RISK REDUCTION AND LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ANGINA: RESULTS FROM COURAGE TRIAL

D. Berman, L. Shaw, J. Min, 2010 .

Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.

E. Bini, S. Sedlis, Andrew Zinn, 2009, European journal of gastroenterology & hepatology.

Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization.

I. Lobach, S. Sedlis, B. Toklu, 2012, The Journal of invasive cardiology.

L. Shaw, J. Spertus, B. Chaitman, 2011, Journal of the American College of Cardiology.

Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.

J. Spertus, P. Hartigan, R. O'rourke, 2009, The American journal of cardiology.

Erratum to: Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Binita Shah, J. Berger, Nicole Allen, 2015, Inflammation.

Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

G. Rioufol, Y. Takeishi, D. Lai, 2014, Journal of the American College of Cardiology.

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

J. Spertus, H. Suryapranata, A. Bagai, 2024, Journal of the American Heart Association.

Prognostic Value of Fractional Flow Reserve Linking Physiologic Severity to Clinical Outcomes

G. Rioufol, Y. Takeishi, E. Belle, 2015 .

Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).

J. Spertus, P. Hartigan, W. Boden, 2015, The American journal of cardiology.